CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 10-K/A Report 10-K/A
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- S-3ASR Offering Registration Statement
- RW Other RW
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 17 of 33 · 660 filings